Skip to content
Clinical Trials – home
Maia Biotechnology Inc.
Sponsor

Maia Biotechnology Inc.

United States 444 West Lake Street Suite 1700, 60606-0070, United States

About the sponsor

Maia Biotechnology Inc. focuses its clinical research on advanced and metastatic non-small cell lung cancer, with interest in later-line treatment settings and outcomes for patients whose disease has progressed after prior therapy.

  • Advanced NSCLC
  • Metastatic NSCLC
  • Third-line treatment

The sponsor’s oncology portfolio centers on evaluating therapeutic options for lung cancer patients needing additional disease control, with emphasis on survival benefit, efficacy, and tolerability in difficult-to-treat disease.

About Specializations

Maia Biotechnology Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage IV, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.